Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Angiosarcoma”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Early research (Phase 1)Study completedNCT00413075
What this trial is testing

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma
Valerio Therapeutics 121
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Not applicableEnded earlyNCT05729425
What this trial is testing

Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin

Who this might be right for
Skin Angiosarcoma
Mayo Clinic 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03921008
What this trial is testing

Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

Who this might be right for
Cutaneous Angiosarcoma
Washington University School of Medicine 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04339738
What this trial is testing

Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

Who this might be right for
Skin AngiosarcomaSkin Radiation-Related AngiosarcomaVisceral Angiosarcoma
National Cancer Institute (NCI) 90
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Looking for participantsNCT07655570
What this trial is testing

Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

Who this might be right for
Cutaneous Angiosarcoma
M.D. Anderson Cancer Center 10
Early research (Phase 1)WithdrawnNCT05799612
What this trial is testing

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Who this might be right for
Angiosarcoma
M.D. Anderson Cancer Center
Not applicableStudy completedNCT04293289
What this trial is testing

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Who this might be right for
Malignant MelanomaAngiosarcoma
Cancer Intelligence Care Systems, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03069378
What this trial is testing

Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SarcomaEpithelioid SarcomaCutaneous Angiosarcoma
Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT03921073
What this trial is testing

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

Who this might be right for
Angiosarcoma of Skin
H. Lee Moffitt Cancer Center and Research Institute 5
Testing effectiveness (Phase 2)Looking for participantsNCT06673628
What this trial is testing

Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients

Who this might be right for
Angiosarcoma of SkinAngiosarcoma Metastatic
National Cancer Center, Japan 38
Early research (Phase 1)Looking for participantsNCT05607095
What this trial is testing

LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Who this might be right for
Uveal MelanomaMelanomaMetastatic Uveal Melanoma+1 more
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Testing effectiveness (Phase 2)Study completedNCT04518124
What this trial is testing

Propranolol in Angiosarcoma

Who this might be right for
Angiosarcoma
The Netherlands Cancer Institute 14
Testing effectiveness (Phase 2)Study completedNCT03544567
What this trial is testing

Oraxol in Subjects With Cutaneous Angiosarcoma

Who this might be right for
Angiosarcoma of Skin
Athenex, Inc. 48